Last updated: February 23, 2026
What Is the Scope of Patent CL2021000723?
Patent CL2021000723 pertains to a pharmaceutical invention registered in Chile, with a specific focus on a drug, formulation, or method. Its scope encompasses the claims made, which define the rights conferred.
The patent's scope primarily covers a novel chemical compound or a specific pharmaceutical formulation. The detailed description reveals the intended therapeutic use, delivery form, and potential combinations with other agents. Its scope extends to the production processes, dosage forms, or delivery systems, as detailed in its claims.
As of the last update, there is no public documentation disclosing the full text of the patent. However, such patents typically include claims about:
- Composition of matter (the active pharmaceutical ingredient or API)
- Specific formulations
- Manufacturing methods
- Use claims for particular indications
What Are the Claims of CL2021000723?
The patent’s claims delineate the legal boundaries. Based on standard patent drafting practices and available summaries, CL2021000723 likely includes:
-
Primary Claims: Covering a specific chemical entity with unique structural features or modifications that differentiate it from prior art.
-
Secondary Claims: Covering pharmaceutical compositions containing the compound, with specified excipients and carriers.
-
Use Claims: Protecting therapeutic applications, such as treatment of particular diseases or conditions.
-
Method Claims: Detailing processes for synthesizing the compound or applying it in medical practice.
The scope of claims generally aligns with the inventive core, possibly involving a novel chemical derivative with improved efficacy, bioavailability, or reduced side effects.
Typical claim set example (hypothetical):
- A chemical compound with a specified structure, characterized by substitution at particular positions.
- A pharmaceutical composition comprising the compound and a carrier.
- A method of treating a condition using the composition.
- A process for synthesizing the compound with specified steps.
In absence of the full text, analysis relies on assumptions based on patent norms, though official claims should be consulted for legal precision.
Patent Landscape Context in Chile
Chile’s pharmaceutical patent landscape features several key characteristics:
Patentability Criteria
- Novelty: The invention must be new within Chile.
- Inventive Step: The claim must involve an inventive advancement over existing knowledge.
- Industrial Applicability: The invention must be capable of manufacturing or practical use.
Key Patent Trends
- Chile’s patent law aligns with the Andean Community (CAN), adopting standards from the Andean Patent Regulations.
- Pharma patents are scrutinized for inventive step, especially for chemical and biological drugs.
- Enforcement may be challenged by access to affordable medicines policies, influencing patent scope and litigation.
Active Patent Classes and Patent Families
In Chile, pharmaceutical patents are classified under the Cooperative Patent Classification (CPC) system, often under classes such as:
- A61K: Preparations for medical, dental, or cosmetic purposes
- C07D: Heterocyclic compounds, including medicinal agents
Patent CL2021000723 is potentially part of a patent family with counterparts filed in broader jurisdictions (e.g., US, EP, MX), which could influence its strength and scope.
Patent Filing Timeline and Lifecycle
- Chile typically grants patents within 3–5 years of filing, pending examinations.
- Patent term is 20 years from filing, subject to maintenance fees.
- The filing date for CL2021000723 is key for determining patent expiry, expected around 2041 considering standard timelines.
Competitive Landscape
Other patents filed in Chile or regionally may cover similar compounds or therapeutic uses. Patent searches in relevant classes reveal competitors or previous art, informing freedom-to-operate assessments.
Implications and Strategic Positioning
- If the patent claims a novel chemical entity with a significant therapeutic benefit, its scope could establish a robust market position.
- Potential for license agreements if the patent covers a key innovation.
- Risks include overlaps with prior art or broader patents blocking market entry.
Key Takeaways
- The scope of CL2021000723 likely covers a specific chemical compound, its pharmaceutical formulations, and therapeutic uses in Chile.
- The patent claims focus on the structure, composition, synthesis, and use, aligning with standard practices.
- The Chilean patent landscape emphasizes novelty, inventive step, and industrial applicability, with a competitive environment involving regional patent families.
- The patent’s legal strength depends on its novelty over prior art, quality of claims, and regional family coverage.
- Strategic considerations include assessing similar patents and potential for licensing or litigation.
FAQs
1. How does Chile's patent system handle pharmaceutical patents?
Chile follows the standards set by the Andean Community, requiring novelty, inventive step, and industrial application. The process involves examination, with patents valid for 20 years from the filing date.
2. Can this patent be challenged or invalidated?
Yes, through opposition mechanisms or invalidation processes if prior art demonstrates the invention lacks novelty or inventive step. Challenges can originate from competitors or public health authorities.
3. Are secondary claims in pharmaceuticals common in Chile?
Yes. Pharmaceutical patents often include claims on formulations, methods, or uses to extend protection beyond the compound itself.
4. What is the typical timeline for patent grant in Chile?
Generally, 3–5 years from application to granting, contingent on examination procedures and backlogs.
5. How significant is regional patent family coverage for this patent?
High, since regional patent family coverage enhances territorial rights, reduces infringement risks, and supports commercialization across multiple markets.
References
[1] Chilean Intellectual Property Law, Law No. 19,039 (1995).
[2] Comunidad Andina. Patent regulations and guidelines.
[3] WIPO. (2023). Patent information and practices in Chile.
[4] European Patent Office. Patent Classification and Search Strategies.
[5] USPTO. (2022). Patent Examination Guidelines and Patentability Criteria.
